MX2016005883A - Formulaciones de acido poliinosinico-policitidilico (poli (i:c))para el tratamiento de infecciones del tracto respiratorio superior. - Google Patents

Formulaciones de acido poliinosinico-policitidilico (poli (i:c))para el tratamiento de infecciones del tracto respiratorio superior.

Info

Publication number
MX2016005883A
MX2016005883A MX2016005883A MX2016005883A MX2016005883A MX 2016005883 A MX2016005883 A MX 2016005883A MX 2016005883 A MX2016005883 A MX 2016005883A MX 2016005883 A MX2016005883 A MX 2016005883A MX 2016005883 A MX2016005883 A MX 2016005883A
Authority
MX
Mexico
Prior art keywords
poly
respiratory tract
upper respiratory
polycytidylic acid
polylnosinic
Prior art date
Application number
MX2016005883A
Other languages
English (en)
Inventor
Mario Lodewijk KLINGELEERS Didier
Henri Van Dijck Alex
MENSCH Jurgen
Original Assignee
Janssen Sciences Ireland Uc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Uc filed Critical Janssen Sciences Ireland Uc
Publication of MX2016005883A publication Critical patent/MX2016005883A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se relaciona con una composición que comprende micropartículas de ácido poliinosínico-policitidílico (poli (I:C)) y un polímero portador seleccionado del grupo de almidón de chícharo, almidón pre-gelatinizado de papa, lactosa, celulosa microcristalina, hialuronato o glucosamina para usarse en la prevención y/o el tratamiento de infecciones virales del tracto respiratorio superior o resfriado común y un dispositivo, de preferencia un sistema de suministro nasal, que comprende dicha composición para ser usada por un paciente que lo necesita, para evitar y/o tratar infecciones o el resfriado común.
MX2016005883A 2013-11-06 2014-11-05 Formulaciones de acido poliinosinico-policitidilico (poli (i:c))para el tratamiento de infecciones del tracto respiratorio superior. MX2016005883A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13191742 2013-11-06
PCT/EP2014/073762 WO2015067632A1 (en) 2013-11-06 2014-11-05 Polylnosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections

Publications (1)

Publication Number Publication Date
MX2016005883A true MX2016005883A (es) 2016-08-17

Family

ID=49517426

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016005883A MX2016005883A (es) 2013-11-06 2014-11-05 Formulaciones de acido poliinosinico-policitidilico (poli (i:c))para el tratamiento de infecciones del tracto respiratorio superior.

Country Status (11)

Country Link
US (1) US20160271165A1 (es)
EP (1) EP3065714B1 (es)
JP (1) JP6629216B2 (es)
KR (1) KR20160072140A (es)
CN (1) CN105939709A (es)
AU (1) AU2014345667A1 (es)
CA (1) CA2929142A1 (es)
IL (1) IL245412A0 (es)
MX (1) MX2016005883A (es)
RU (1) RU2016117398A (es)
WO (1) WO2015067632A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201406208QA (en) 2012-05-03 2014-11-27 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
AU2016259869A1 (en) * 2015-05-11 2017-11-30 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (Poly(I:C)) pea starch formulation for the prevention and/or treatment of upper respiratory tract infections
GB2555364A (en) 2015-11-17 2018-04-25 Grund IP Group Novel pharmaceutical composition comprising particles comprising a complex of a double-stranded polyribonucleotide and polyalkyleneimine
TW201825102A (zh) 2016-11-16 2018-07-16 愛爾蘭商健生科學愛爾蘭無限公司 用於預防上呼吸道感染之聚肌苷酸及聚胞苷酸之調配物
PL3448363T3 (pl) 2017-05-17 2022-09-26 Highlight Therapeutics, S.L. Nowa kompozycja farmaceutyczna zawierająca cząstki zawierające kompleks dwuniciowego polirybonukleotydu i polialkilenoiminy
KR102123489B1 (ko) 2020-03-13 2020-06-16 주식회사 휴먼셀바이오 자연살해세포 배양액 조성물 및 이를 이용한 자연살해세포 배양방법
AU2021258392A1 (en) 2020-04-19 2022-12-15 Ludwig ENGLMEIER Prophylaxis and treatment of coronavirus infection

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707644A (en) * 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
CN101229378A (zh) * 2005-05-05 2008-07-30 国家淀粉及化学投资控股公司 用于送递活性剂的组合物
US20070166239A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
CN101491503A (zh) * 2008-12-17 2009-07-29 天津瑞普生物技术股份有限公司 一种用于宠物的聚肌胞滴丸及其制备方法
CN101757018A (zh) * 2008-12-24 2010-06-30 天津瑞普生物技术股份有限公司 一种用于畜禽的聚肌胞干粉及其制备方法
CN102488703A (zh) * 2011-12-15 2012-06-13 天津济命生生物科技有限公司 一种聚肌胞制剂的制备方法和抗肿瘤的用途
SG11201406208QA (en) * 2012-05-03 2014-11-27 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections

Also Published As

Publication number Publication date
CA2929142A1 (en) 2015-05-14
CN105939709A (zh) 2016-09-14
US20160271165A1 (en) 2016-09-22
IL245412A0 (en) 2016-06-30
RU2016117398A3 (es) 2018-08-22
JP2016535094A (ja) 2016-11-10
EP3065714A1 (en) 2016-09-14
WO2015067632A1 (en) 2015-05-14
KR20160072140A (ko) 2016-06-22
RU2016117398A (ru) 2017-12-11
JP6629216B2 (ja) 2020-01-15
AU2014345667A1 (en) 2016-05-19
EP3065714B1 (en) 2020-02-12

Similar Documents

Publication Publication Date Title
MX2016005883A (es) Formulaciones de acido poliinosinico-policitidilico (poli (i:c))para el tratamiento de infecciones del tracto respiratorio superior.
MY169159A (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
PH12015502261A1 (en) Macrocyclic deaza-purinones for the treatment of viral infections
PH12015500274A1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
PH12015500983A1 (en) Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
MX367915B (es) Derivados de 2-aminopirimidina para el tratamiento de infecciones viricas.
PH12015500724B1 (en) 1, 2, 4-triazine derivatives for the treatment of viral infections
MX347596B (es) Derivados de purina para el tratamiento de infecciones viricas.
EP2493464A4 (en) METHYLSULFONYLMETHANE (MSM) FOR THE TREATMENT OF DRUG-RESISTANT MICROORGANISMS
PH12015500713B1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
MX2019002669A (es) Composicion farmaceutica para usarse en el tratamiento de la malnutricion en un sujeto que exhibe un trastorno de espectro de autismo (asd).
MX2014013256A (es) Formulaciones de acido poliinosinico-policitidilico (poli(i:c)) para el tratamiento de infecciones de las vias respiratorias altas.
MX2023000796A (es) Composicion farmaceutica, metodos para tratamiento y sus usos.
MD3229816T2 (ro) Polimeri de legare a protonilor pentru administrare orală
MX2017007054A (es) Composiciones y métodos para usar solabegron de liberación modificada para sintomas del tracto urinario inferior.
HK1251926A1 (zh) 用於預防和/或治療上呼吸道感染的聚肌苷酸-聚胞苷酸(聚(i:c))豌豆澱粉製劑
UA118474C2 (uk) (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
MX2018004779A (es) Uso terapeutico de una solucion oftalmica acuosa esteril.
MX2019004736A (es) Mini-tabletas de melatonina y metodos de fabricacion de las mismas.
TR201903234T4 (tr) Parkinson hastalığının tedavisinde kullanılmaya yönelik dopamin içeren farmasötik çözelti.
WO2014186252A3 (en) Flushable catheter affixed to a wash line activated by a microfluidic pressure switch
PH12016501127A1 (en) Adenosine a1 agonists as medicaments against renal diseases
MX2018005453A (es) Uso terapeutico de una solucion oftalmica acuosa esteril.
NZ631362A (en) Arry-520 for use in treating cancer in a patient with low aag
UA73699U (ru) Применение комплексного антимикробного сорбционно-протеолитического препарата Сертасил как средства для лечения гнойных ран, трофических язв, ожогов в ветеринарии